
PhaseV is a Boston-based technology company that leverages advanced causal machine learning and GenAI, augmented by an expansive data lake and real-world data (RWD), to empower biopharma sponsors and CROs with fast, accurate, and efficient clinical development decisions. The company offers a comprehensive suite of AI-powered solutions that optimize every phase of the clinical trial process, helping clients to rapidly design and implement adaptive and Bayesian clinical trials, analyze data for heterogeneous treatment effects, and improve trial planning. With over 30 biopharma and CRO customers and a commitment to transforming clinical development, PhaseV is positioned to bring new treatments to patients more efficiently.

PhaseV is a Boston-based technology company that leverages advanced causal machine learning and GenAI, augmented by an expansive data lake and real-world data (RWD), to empower biopharma sponsors and CROs with fast, accurate, and efficient clinical development decisions. The company offers a comprehensive suite of AI-powered solutions that optimize every phase of the clinical trial process, helping clients to rapidly design and implement adaptive and Bayesian clinical trials, analyze data for heterogeneous treatment effects, and improve trial planning. With over 30 biopharma and CRO customers and a commitment to transforming clinical development, PhaseV is positioned to bring new treatments to patients more efficiently.
What they do: AI/ML platform and services to optimize clinical trial design, execution, and operations using causal machine learning and large real-world data
Headquarters: Cambridge/Boston, MA
Founding year: 2023
Customers: 30+ biopharma and CRO customers
Funding: Raised tens of millions; Series A announced May 13, 2025
Clinical trial optimization for biopharma sponsors and CROs using AI/ML and real‑world data
2023
Pharmaceutical Manufacturing
“Accel; Insight Partners; Exor Ventures; LionBird; Viola Ventures; GETTY”
About Us Position Overview We are seeking a seasoned and strategic Head of Project Management to lead and scale PhaseV's global project management organization. This leader will own the delivery excellence of our partnerships with biotech, CRO, and pharma clients, ensuring smooth execution across multiple scientific, technical, and operational workstreams.
You will define the project management function as a strategic growth engine—aligning cross-functional efforts from formation through delivery, and shaping how PhaseV engages, executes, and expands with customers across all programs.
This is a critical leadership role for a proactive, highly organized, and scientifically fluent professional who can balance strategic oversight with hands-on leadership in a rapidly scaling environment.
About Us PhaseV (HQ in Boston, R&D in Tel Aviv) is a startup at the forefront of advancing clinical trials through innovation and technology. We leverage cutting-edge causal machine learning , as well as advanced software, to transform the way clinical trials are designed, executed, and analyzed.
Our team combines technology, machine learning, and data science expertise with deep clinical and pharma experience—bridging the latest advancements in AI with real-world clinical development.
We have built a proprietary platform for the design and execution of advanced clinical trials and developed a causal-ML pipeline for retrospective analysis.Raised $65M in funding so far,to accelerate our growth and impact across the life sciences industry.
Key Responsibilities Strategic Leadership & Scale
Project Delivery & Execution Excellence
Cross-Functional Alignment
Client Growth & Relationship Management
Minimum Qualifications
Preferred Qualifications
What We Offer
Competitive compensation, equity participation, and professional growth opportunities.
| Company |
|---|